| Issue Date | Title | Author(s) |
| 2017-07-18 | Integrative Genomics Identifies the Molecular Basis of Resistance to Azacitidine Therapy in Myelodysplastic Syndromes | Unnikrishnan, A; Papaemmanuil, E; Beck, D; Deshpande, NP; Verma, A; Kumari, A; Woll, PS; Richards, LA; Knezevic, K; Chandrakanthan, V; Thoms, JAI; Tursky, ML; Huang, Y; Ali, Z; Olivier, J; Galbraith, S; Kulasekararaj, AG; Tobiasson, M; Karimi, M; Pellagatti, A; Wilson, SR; Lindeman, R; Young, B; Ramakrishna, R; Arthur, C; Stark, R; Crispin, P; Curnow, J; Warburton, P; Roncolato, F; Boultwood, J; Lynch, K; Jacobsen, SEW; Mufti, GJ; Hellstrom-Lindberg, E; Wilkins, MR; MacKenzie, KL; Wong, JWH; Campbell, PJ; Pimanda, JE |
| 2016-12-01 | A quantitative proteomics approach identifies ETV6 and IKZF1 as new regulators of an ERG-driven transcriptional network | Unnikrishnan, A; Guan, YF; Huang, Y; Beck, D; Thoms, JAI; Peirs, S; Knezevic, K; Ma, S; De Walle, IV; De Jong, IDE; Ali, Z; Zhong, L; Raftery, MJ; Taghon, T; Larsson, J; MacKenzie, KL; Van Vlierberghe, P; Wong, JWH; Pimanda, JE |
| 2013-10-10 | Genome-scale expression and transcription factor binding profiles reveal therapeutic targets in transgenic ERG myeloid leukemia | Goldberg, L; Tijssen, MR; Birger, Y; Hannah, RL; Kinston, SJ; Schütte, J; Beck, D; Knezevic, K; Schiby, G; Jacob-Hirsch, J; Biran, A; Kloog, Y; Marcucci, G; Bloomfield, CD; Aplan, PD; Pimanda, JE; Göttgens, B; Izraeli, S |
| 2018-09-15 | Disruption of a 35 KB enhancer impairs CTCF binding and MLH1 expression in colorectal cells | Liu, Q; Thoms, JAI; Nunez, AC; Huang, Y; Knezevic, K; Packham, D; Poulos, RC; Williams, R; Beck, D; Hawkins, NJ; Ward, RL; Wong, JWH; Hesson, LB; Sloane, MA; Pimanda, JE |
